Skip to main content
    Kriv AI

    Life Sciences & Clinical Research Governance

    Clinical AI Validation Consulting Under GCP and GAMP 5

    What ICH E6(R3) Good Clinical Practice and GAMP 5's expanded AI/ML guidance require before an AI system touches a clinical trial, and how Kriv AI validates against both.

    Clinical AI validation under GCP and GAMP 5 means proving an AI system used in a clinical trial, from patient recruitment to safety monitoring, meets ICH E6(R3)'s quality-by-design principles and GAMP 5's risk-based computerized system validation, now expanded to cover AI/ML.

    context

    What GCP and GAMP 5 Actually Require

    A clinical AI system answers to two separate standards at once: the trial-conduct rules in Good Clinical Practice, and the system-validation rules that govern any computerized system used in a regulated life sciences process.

    ICH E6(R3): quality by design across the trial lifecycle

    ICH E6(R3), the modernized Good Clinical Practice guideline, was adopted on January 6, 2025 and restructured GCP into overarching Principles plus Annex 1 (interventional trials). A separate Annex 2, covering non-traditional trial designs, reached ICH Step 4 in June 2026 and applies in the EU from 15 January 2027. The Principles and Annex 1 applied in the EU from 23 July 2025, and the FDA published the guideline as final guidance on 9 September 2025. The revision moves away from a prescriptive checklist toward risk-based, proportionate quality management: sponsors identify what is critical to participant safety and data integrity, then scale oversight to that risk, rather than applying uniform monitoring to every process regardless of its actual risk.

    GAMP 5: validating the computerized systems that run the trial

    GAMP 5 is ISPE's risk-based framework for validating GxP computerized systems, and it is the validation methodology most clinical trial systems are built and audited against. Its Second Edition expanded the appendices to cover modern topics, including Artificial Intelligence/Machine Learning, alongside blockchain, cloud computing, and open-source software. ISPE followed that in July 2025 with a standalone GAMP Guide: Artificial Intelligence, a full-length document extending GAMP 5's principles specifically to AI-enabled systems across data governance, model risk management, and change control.

    ai gap

    Why AI Complicates Both Standards at Once

    A clinical AI system, one triaging adverse event reports, screening candidates for trial eligibility, or drafting sections of a clinical study report, sits inside a trial governed by GCP and runs on a computerized system governed by GAMP 5. GCP asks whether the trial's quality management is proportionate to risk to participants and data integrity. GAMP 5 asks whether the system itself was validated for its intended use. An AI model that produces different output on repeated runs strains GAMP 5's traditional deterministic test-script approach, which is exactly why ISPE expanded GAMP 5's appendices for AI/ML and published a standalone AI guide.

    Neither standard exempts AI from its requirements. A trial team cannot point to E6(R3)'s new flexibility as a reason to skip system validation, and cannot point to GAMP 5's system-level validation as a reason to skip GCP's participant-risk oversight. Both apply, together, to the same AI system. For device makers, our guide to the FDA computer software assurance (CSA) guidance covers software used in production and quality systems, which is a different setting from a clinical trial.

    framework

    How the Two Standards Fit Together for a Clinical AI System

    Under E6(R3)'s risk-based quality management, a sponsor first identifies which trial processes and data are critical to participant safety and trial results, then designs monitoring proportionate to that risk. GAMP 5 supplies the system-validation method for anything on that critical list: a risk classification, a validation plan, and, for AI/ML systems specifically, structured evaluation of training data, performance metrics, and drift monitoring per GAMP 5's AI/ML appendix coverage and the July 2025 ISPE AI guide.

    This is also where FDA's parallel January 2025 draft guidance on AI in regulatory submissions applies: it proposes a risk-based credibility framework, scaled to an AI model's context of use, that maps onto the same risk-tiering exercise GAMP 5 already requires. A sponsor running one risk assessment can address FDA's AI credibility expectations and GAMP 5's validation requirements together, rather than building two parallel programs for the same system.

    engagement

    What a GCP/GAMP 5 Clinical AI Validation Engagement Includes

    The work starts with an inventory of every AI or ML system touching trial data, patient interaction, or safety reporting, each mapped to its GCP risk category and its GAMP 5 system classification.

    Validation follows GAMP 5's risk-based method, adapted for non-deterministic AI output per its expanded AI/ML appendix coverage: structured output sampling against a scoring rubric, documented review of a representative output sample, and ongoing drift monitoring, all captured in an audit trail that satisfies E6(R3)'s record and oversight expectations.

    The deliverable is a validation package built to satisfy an inspector working from either standard: the E6(R3) risk-based quality management rationale, the GAMP 5 validation protocol and supporting evidence, and the ongoing monitoring plan, not a one-time slide deck.

    tiers

    What You Get at Each Tier

    1. 1. Enterprise / regulated (clinical research, life sciences, pharma)

      A full clinical AI validation program: system inventory, GCP risk categorization under E6(R3), a GAMP 5 system classification and validation protocol adapted for AI/ML, and an audit-trail package ready for inspection.

    2. 2. Fractional AI governance lead

      Ongoing oversight of the validation program as new AI tools enter trial operations, plus regular reporting to clinical quality and regulatory affairs leadership.

    3. 3. Specialized advisory

      Targeted review of a single AI system's validation package, or a second opinion ahead of an FDA inspection or sponsor audit.

    engagement

    How engagements are scoped and priced

    Every engagement is scoped and priced after a short discovery call.

    Straight answers

    Frequently asked questions about Clinical AI Validation Consulting Under GCP and GAMP 5

    What is ICH E6(R3)?

    ICH E6(R3) is the 2025 update to the international Good Clinical Practice guideline, restructured into overarching Principles and Annex 1 for interventional trials. A separate Annex 2, for non-traditional trial designs, reached ICH Step 4 in June 2026 and applies in the EU from 15 January 2027. It is built around risk-based, proportionate quality management.

    What is GAMP 5 and how does it relate to clinical trials?

    GAMP 5 is ISPE's risk-based framework for validating GxP computerized systems, including the systems that run clinical trials. Its Second Edition expanded its appendices to cover AI/ML, and ISPE published a standalone GAMP Guide: Artificial Intelligence in July 2025.

    Does GCP require validating an AI model used in a trial?

    Yes. If an AI system touches trial data, patient interaction, or safety reporting, it falls inside both E6(R3)'s risk-based quality management and GAMP 5's system-validation requirements, regardless of whether the system is deterministic software or an AI model.

    How is an AI model validated if its output changes between runs?

    Through structured output sampling against a scoring rubric, documented review of a representative sample of outputs, and ongoing drift monitoring, the approach GAMP 5's expanded AI/ML appendix coverage and ISPE's AI guide describe, rather than the single deterministic test script used for traditional software validation.

    What does GCP/GAMP 5 clinical AI validation consulting cost?

    Every engagement is scoped and priced after a short discovery call.

    Does Kriv AI work with small clinical-stage biotechs?

    Kriv AI's own consulting practice focuses on enterprise and regulated life sciences organizations.

    Talk to the team that would do the work

    Bring your requirements to a working session with the person who'll actually deliver.

    Book a Discovery Call